Starpharma Holdings Limited
SPHRF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $44 | $47 | $42 | $66 |
| - Cash | $15 | $20 | $23 | $32 |
| + Debt | $2 | $2 | $4 | $3 |
| Enterprise Value | $31 | $29 | $22 | $37 |
| Revenue | $3 | $2 | $2 | $7 |
| % Growth | 41% | 40.2% | -75.9% | – |
| Gross Profit | -$1 | -$2 | -$3 | $6 |
| % Margin | -43% | -93% | -201.6% | 89.3% |
| EBITDA | -$4 | -$5 | -$7 | -$3 |
| % Margin | -130.6% | -216.5% | -403.4% | -36.8% |
| Net Income | -$5 | -$5 | -$7 | -$1 |
| % Margin | -134.3% | -222.2% | -412% | -14.4% |
| EPS Diluted | -0.011 | -0.013 | -0.017 | -0.003 |
| % Growth | 15.4% | 24.9% | -592% | – |
| Operating Cash Flow | -$5 | -$2 | -$9 | $2 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$5 | -$2 | -$9 | $2 |